• レポートコード:PMR2008044 • 出版社/出版日:Persistence Market Research / 2020年5月13日 • レポート形態:英文、PDF、195ページ • 納品方法:Eメール • 産業分類:生命科学 |
Individual User(1名用) | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Multi User(5名用) | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Corporate User(企業用) | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、インフルエンザワクチンの世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、需要分析・予測、市場背景、製品種類別(三価インフルエンザワクチン、四価インフルエンザワクチン)分析、剤形別(筋肉内注射、鼻スプレー、皮内注射)分析、流通チャネル別(機関、小売り)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・需要分析・予測 ・市場背景 ・インフルエンザワクチンの世界市場規模:製品種類別(三価インフルエンザワクチン、四価インフルエンザワクチン) ・インフルエンザワクチンの世界市場規模:剤形別(筋肉内注射、鼻スプレー、皮内注射) ・インフルエンザワクチンの世界市場規模:流通チャネル別(機関、小売り) ・インフルエンザワクチンの世界市場規模:地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Flu Vaccine Market – Analysis and Opportunity Assessment
Persistence Market Insights (PMR), in its new publication, outlines the growth trails of ‘Flu Vaccine Market’ for the period between 2020 and 2030. The study includes a thorough analysis of historical and current trends that can impact the future development of flu vaccine market. It offers various drivers, restrains, challenges, and opportunities in the flu vaccine market. The report brings to fore actionable insights on nodes and internodes of the flu vaccine market that can arm the vendors with necessary information to take critical decision with confidence.
PMR’s study covers a key indicator assessment to estimate the growth prospects of the flu vaccine market during the predefined period, along with forecast statistics in terms of value (US$ million). In addition, the report consists of multiple sections explaining the global healthcare spending outlook and awareness about flu and flu vaccination.
Readers can find a detailed taxonomy in the report, along with an incisive outlook on the competitive landscape in flu vaccine market. The study profiles a number of incumbent companies and new entrants in the flu market, wherein, product portfolio, new launches, technological innovations, and dynamic growth strategies of these players have been detailed.
What are the Key Questions Answered in the Flu Vaccine Market Report?
PMR’s study assesses the flu vaccine market at both macroscopic and microscopic levels to offer detailed insights that can help determine sustained opportunities for the stakeholders. Exclusive information provided in the flu vaccine market report addresses various important questions required to understand and gain comprehensive knowledge about the market. Some of these questions are:
How is regulatory framework in different nations affecting the growth of flu vaccine market?
How has the flu vaccine market performed so far and how will it perform in the next decade?
What are winning strategies of key players in the flu vaccine market?
What are the opportunities market stakeholders are eyeing to strengthen their position in the global market?
What are development risks and competitive threats faced by the flu vaccine market players across different regions?
Research Methodology
The research methodology followed for obtaining complete information regarding the developments in flu vaccine market involves conducting an in-depth market research with the help of various primary and secondary resources. By analyzing the information gathered through and verified by these resources, analysts could offer exclusive insights on how the flu vaccine market will grow and expand during the predefined period.
Analysts have conducted interviews and discussion with healthcare consultants, CEOs, KOLs, regional officers, and sales managers of companies in the supply chain of flu vaccine drugs. The data obtained through these discussions have contributed to the development of the flu vaccine market report as a primary resource.
Secondary resources referred by the analysts for the compilation of flu vaccine market report include company annual and financial reports_bk_01_01_2020, white papers, industrial association publications, research publications, and leading industry magazines. Other secondary resources are Global Alliance of Vaccine and Immunization (Gavi), International Society of Vaccines, and IFPMA.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Recent Developments
1.3. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
4. Global Flu Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
4.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
4.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Spending Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Vaccination Rate
5.2.2. Awareness about Flu and Flu Vaccination
5.2.3. Availability of Flu Vaccines
5.2.4. Demand for Flu Vaccines in Different Countries
5.2.5. Collaboration among manufacturers
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015-2019
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
6.3.1. Trivalent Flu Vaccines
6.3.2. Quadrivalent Flu Vaccines
6.4. Market Attractiveness Analysis By Product Type
7. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Dosage Form
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Dosage Form, 2015-2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dosage Form, 2020-2030
7.3.1. Intramuscular Injection
7.3.2. Nasal Spray
7.3.3. Intradermal Shot
7.4. Market Attractiveness Analysis By Dosage Form
8. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030
8.3.1. Institutional Sales
8.3.1.1. Hospitals
8.3.1.2. Community Clinics
8.3.1.3. Public Health Agencies
8.3.1.4. Workplace Purchasing
8.3.2. Retail Sales
8.3.2.1. Retail Pharmacy
8.3.2.2. Mail Order Pharmacy
8.4. Market Attractiveness Analysis By Distribution Channel
9. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2015-2019
9.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2020-2030
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
10.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Product Type
10.3.3. By Dosage Form
10.3.4. By Distribution Channel
10.4. Market Attractiveness Analysis
10.5. Drivers and Restraints – Impact Analysis
11. Latin America Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.2. By Product Type
11.3.3. By Dosage Form
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.5. Drivers and Restraints – Impact Analysis
12. Europe Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. BENELUX
12.3.1.7. Russia
12.3.1.8. Rest of Europe
12.3.2. By Product Type
12.3.3. By Dosage Form
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Drivers and Restraints – Impact Analysis
13. South Asia Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
13.4.1. By Country
13.4.1.1. India
13.4.1.2. Thailand
13.4.1.3. Indonesia
13.4.1.4. Malaysia
13.4.1.5. Rest of South Asia
13.4.2. By Product Type
13.4.3. By Dosage Form
13.4.4. By Distribution Channel
13.5. Market Attractiveness Analysis
13.6. Drivers and Restraints – Impact Analysis
14. East Asia Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product Type
14.3.3. By Dosage Form
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints – Impact Analysis
15. Oceania Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Australia
15.3.1.2. New Zealand
15.3.2. By Product Type
15.3.3. By Dosage Form
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints – Impact Analysis
16. Middle East and Africa Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. Turkey
16.3.1.3. Northern Africa
16.3.1.4. South Africa
16.3.1.5. Rest of Middle East and Africa
16.3.2. By Product Type
16.3.3. By Dosage Form
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints – Impact Analysis
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies (Flu Vaccines)
17.2. Market Share Analysis of Top Players
17.3. Market Presence Analysis
17.3.1. By Regional footprint of Players
17.3.2. Product foot print by Players
17.3.3. Channel Foot Print by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Sanofi Pasteur Inc. (Sanofi S/A)
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Profitability by Market Segments (Product/Channel/Region)
18.3.1.4. Sales Footprint
18.3.1.5. Strategy Overview
18.3.1.5.1. Marketing Strategy
18.3.1.5.2. Product Strategy
18.3.1.5.3. Channel Strategy
18.3.2. AstraZeneca
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Profitability by Market Segments (Product/Channel/Region)
18.3.2.4. Sales Footprint
18.3.2.5. Strategy Overview
18.3.2.5.1. Marketing Strategy
18.3.2.5.2. Product Strategy
18.3.2.5.3. Channel Strategy
18.3.3. CSL Ltd. (Seqirus)
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Profitability by Market Segments (Product/Channel/Region)
18.3.3.4. Sales Footprint
18.3.3.5. Strategy Overview
18.3.3.5.1. Marketing Strategy
18.3.3.5.2. Product Strategy
18.3.3.5.3. Channel Strategy
18.3.4. Abbott
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Profitability by Market Segments (Product/Channel/Region)
18.3.4.4. Sales Footprint
18.3.4.5. Strategy Overview
18.3.4.5.1. Marketing Strategy
18.3.4.5.2. Product Strategy
18.3.4.5.3. Channel Strategy
18.3.5. GlaxoSmithKline Plc.
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Profitability by Market Segments (Product/Channel/Region)
18.3.5.4. Sales Footprint
18.3.5.5. Strategy Overview
18.3.5.5.1. Marketing Strategy
18.3.5.5.2. Product Strategy
18.3.5.5.3. Channel Strategy
18.3.6. Serum Institute of India Pvt. Ltd.
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Profitability by Market Segments (Product/Channel/Region)
18.3.6.4. Sales Footprint
18.3.6.5. Strategy Overview
18.3.6.5.1. Marketing Strategy
18.3.6.5.2. Product Strategy
18.3.6.5.3. Channel Strategy
19. Research Methodology
List of TablesTable 01: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 02: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 03: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 04: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 05: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 06: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 07: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 08: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 09: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 10: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 11: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 12: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 13: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 14: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 15: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 16: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 17: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 18: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 19: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 20: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 21: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 22: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 23: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 24: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 25: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 26: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 27: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 28: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 29: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 30: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 31: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 32: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 33: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 34: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 35: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 36: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 37: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 38: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 39: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 40: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
Table 41: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel